| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $19,337,870 ) (Continued on the next page) |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI168543 | Th9 cells and protective TB immunity | 001 | 3 | NIH | 5/24/2024 | $66,759 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI168543 | Th9 cells and protective TB immunity | 000 | 3 | NIH | 2/27/2024 | $600,835 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DC019566 | Pharmacological Approaches for Transepithelial Delivery of Therapeutics to the Vocal Folds | 000 | 3 | NIH | 3/26/2024 | $602,131 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R56AI180725 | Stem-like T cells as bioindicators and orchestrators of the disease process in MS and animal models | 000 | 1 | NIH | 8/12/2024 | $305,000 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | K23DA053433 | A Preconception Health Intervention to Reduce Substance Exposed Pregnancies among Incarcerated Women | 000 | 3 | NIH | 2/16/2024 | $177,480 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AG087308 | Methods for treating aging-related cognitive decline and reducing risk of AD/ADRD by enhancing the endogenous expression of adropin | 000 | 1 | NIH | 4/12/2024 | $416,625 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | D1930852 | Nursing Workforce Diversity | 00 | 8 | HRSA | 6/10/2024 | $541,277 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | U1Q53678 | Geriatrics Workforce Enhancement Program | 01 | 1 | HRSA | 9/10/2024 | $1,742 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | U1Q53678 | Geriatrics Workforce Enhancement Program | 00 | 1 | HRSA | 8/21/2024 | $230,000 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | U1Q53678 | Geriatrics Workforce Enhancement Program | 00 | 1 | HRSA | 8/21/2024 | $770,000 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK122401 | SELECTION OF VACCINE ANTIGENS FOR PROTECTION FROM HEPATITIS C VIRUS INFECTION | 000 | 5 | NIH | 5/9/2024 | $327,240 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK131136 | Role of bile acid receptors FXR and TGR5 in preventing injury in short bowel syndrome | 000 | 4 | NIH | 7/25/2024 | $363,600 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R15GM129731 | Acquiring Nanoparticle Tracking Analysis System to Enhance Lab Productivity and Capability | 000 | 2 | NIH | 5/1/2024 | $98,046 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL147821 | Structural enzymology of factor V activation | 002 | 6 | NIH | 6/13/2024 | $43,905 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL147821 | Structural enzymology of factor V activation | 001 | 6 | NIH | 4/16/2024 | $493,946 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL150146 | Structural Studies of Beta-2 glycoprotein I in the Antiphospholipid Syndrome | 001 | 5 | NIH | 6/13/2024 | $31,092 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL150146 | Structural Studies of Beta-2 glycoprotein I in the Antiphospholipid Syndrome | 000 | 5 | NIH | 1/10/2024 | $349,774 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 003 | 5 | NIH | 7/23/2024 | $511,779 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI142672 | Innate immune response of LTBI+HIV+ children | 004 | 5 | NIH | 8/14/2024 | $726,289 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R35GM154778 | VOLTAGE-SENSING MECHANISMS OF ION CHANNELS IN DYNAMIC LIPID MEMBRANES | 000 | 1 | NIH | 7/3/2024 | $378,750 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM145783 | Structural dynamics of sphingosine-1-phosphate transporters as key therapeutic targets for immune system modulation and cancer | 001 | 2 | NIH | 8/15/2024 | $395,216 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI150610 | Lead optimization of Hepatitis B Virus ribonuclease H inhibitors | 001 | 4 | NIH | 5/15/2024 | $64,221 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI150610 | Lead optimization of Hepatitis B Virus ribonuclease H inhibitors | 000 | 4 | NIH | 10/31/2023 | $577,986 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM145783 | Structural dynamics of sphingosine-1-phosphate transporters as key therapeutic targets for immune system modulation and cancer | 000 | 1 | NIH | 6/6/2024 | $65,243 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | T7635369 | Maternal and Child Health Public Health Training Program | 00 | 5 | HRSA | 4/15/2024 | $348,143 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R03TR005223 | Conditional knock-in of Gnb3/Gngt2 in mouse rod photoreceptors | 000 | 1 | NIH | 7/24/2024 | $151,500 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R15GM154275 | Characterizing the Function and Regulation of Ycx1, a New Member of the CCX Family of Exchangers | 000 | 1 | NIH | 9/3/2024 | $378,750 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | S10OD036230 | High-Sensitivity Bruker Q-Band Elexsys E580 Pulse EPR Spectrometer | 000 | 1 | NIH | 8/23/2024 | $1,746,529 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | S10OD036230 | High-Sensitivity Bruker Q-Band Elexsys E580 Pulse EPR Spectrometer | 000 | 1 | NIH | 8/23/2024 | $1 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK132162 | Determining hepatocyte-specific mechanisms by which Ube4A regulates NAFLD/NASH | 001 | 2 | NIH | 5/15/2024 | $35,432 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK132162 | Determining hepatocyte-specific mechanisms by which Ube4A regulates NAFLD/NASH | 000 | 2 | NIH | 12/8/2023 | $531,461 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM143179 | Mechanism and Regulation of eIF6 in Translation | 002 | 3 | NIH | 8/6/2024 | $61,319 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM143179 | Mechanism and Regulation of eIF6 in Translation | 001 | 3 | NIH | 7/23/2024 | $31,815 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM143179 | Mechanism and Regulation of eIF6 in Translation | 000 | 3 | NIH | 4/9/2024 | $286,335 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | K23AR079035 | Neighborhood Barriers and Facilitators to Walking, the Epidemiology of Knee Osteoarthritis and Developing Effective Exercise Prescriptions | 000 | 3 | NIH | 1/25/2024 | $157,393 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AG089957 | Age, sex, hormonal status, and anti-inflammatory therapy for atherosclerosis | 000 | 1 | NIH | 7/18/2024 | $416,625 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI148362 | HBV RNaseH inhibitors: Effects on HBV biology and resistance development | 001 | 5 | NIH | 5/15/2024 | $37,875 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI148362 | HBV RNaseH inhibitors: Effects on HBV biology and resistance development | 000 | 5 | NIH | 11/15/2023 | $340,875 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AG088932 | Targeted Modulation of Longevity-Associated Genes Using Antisense Oligonucleotides | 000 | 1 | NIH | 8/5/2024 | $416,625 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK134531 | The Role of Inflammation in Regulating Gastric Metaplasia | 001 | 2 | NIH | 5/10/2024 | $33,397 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK134531 | The Role of Inflammation in Regulating Gastric Metaplasia | 000 | 2 | NIH | 12/13/2023 | $500,965 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | F30DK134124 | Defining Inflammatory Triggers that Induce Diverse Subtypes of Gastric Metaplasia | 001 | 2 | NIH | 4/29/2024 | $1,280 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | F30DK134124 | Defining Inflammatory Triggers that Induce Diverse Subtypes of Gastric Metaplasia | 000 | 2 | NIH | 12/7/2023 | $52,694 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01EY031008 | Iron and Diabetic Retinopathy | 000 | 5 | NIH | 1/4/2024 | $378,750 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS114289 | Role of oligomeric TDP-43 aggregate intermediates in ALS and frontotemporal dementia | 001 | 5 | NIH | 7/11/2024 | $23,787 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS114289 | Role of oligomeric TDP-43 aggregate intermediates in ALS and frontotemporal dementia | 001 | 5 | NIH | 7/11/2024 | $11,363 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS114289 | Role of oligomeric TDP-43 aggregate intermediates in ALS and frontotemporal dementia | 001 | 5 | NIH | 7/11/2024 | $2,725 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS114289 | Role of oligomeric TDP-43 aggregate intermediates in ALS and frontotemporal dementia | 000 | 5 | NIH | 1/17/2024 | $320,875 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS114289 | Role of oligomeric TDP-43 aggregate intermediates in ALS and frontotemporal dementia | 000 | 5 | NIH | 1/17/2024 | $20,000 |
|
